REGISTERED
on 31 Jan 2023
Last Applicant/ Owned by
Chuo-ku Tokyo 103-8426
JP
Serial Number
79333486 filed on 16th Dec 2021
Registration Number
6966193 registered on 31st Jan 2023
Correspondent Address
Bassam N. Ibrahim
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
TREYTAQA
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney di Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease, oncolytic virus
Mark Details
Serial Number
No 79333486
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 0076404-236
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Dec 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| 30th May 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 08th May 2023 | FINAL DISPOSITION PROCESSED |
| 08th May 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| 30th Apr 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 31st Jan 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 31st Jan 2023 | REGISTERED-PRINCIPAL REGISTER |
| 15th Nov 2022 | PUBLISHED FOR OPPOSITION |
| 15th Nov 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 26th Oct 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |